Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

G. Sette, Giovanni Sette, V. Salvati, Valentina Salvati, M. Mottolese, P. Visca, E. Gallo, K. Fecchi, E. Pilozzi, E. Duranti, E. Policicchio, M. Tartaglia, Marco Tartaglia, M. Milella, Ruggero De Maria Marchiano, A. Eramo

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

25 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science